Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06437392

Evaluation of Sarcopenia and Related Factors in Patients Diagnosed With Psoriatic Arthritis

Status
Recruiting
Phase
Study type
Observational
Enrollment
102 (estimated)
Sponsor
Ankara City Hospital Bilkent · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is identify the prevalence of sarcopenia and its associated factors in patients with psoriatic arthritis. Furthermore, we aimed to investigate the predictive contribution of USG in diagnosing sarcopenia by assessing the thickness of the rectus femoris, vastus intermedius, and quadriceps muscles in patients with psoriatic arthritis.

Detailed description

After being informed about study and potential risk, all patient and giving written informed consent will undergo screnneing determite eligibility for study entire. Participants who agree to take part in the study and sign the informed consent form will be divided into two groups: patients and healthy volunteers. The patients will undergo a rheumatological examination, and sarcopenia screening will be conducted for both groups. Additionally, the quadriceps muscle thickness of both groups will be measured.

Conditions

Timeline

Start date
2023-06-20
Primary completion
2024-08-20
Completion
2024-08-20
First posted
2024-05-31
Last updated
2024-05-31

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06437392. Inclusion in this directory is not an endorsement.

Evaluation of Sarcopenia and Related Factors in Patients Diagnosed With Psoriatic Arthritis (NCT06437392) · Clinical Trials Directory